Ayala Pharmaceuticals Inc (ADXS)
0.555
+0.02
(+4.62%)
USD |
OTCM |
May 03, 16:00
Ayala Pharmaceuticals Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2022 | -0.005M |
December 31, 2021 | -0.005M |
September 30, 2021 | 0.014M |
June 30, 2021 | -0.026M |
March 31, 2021 | -0.001M |
Date | Value |
---|---|
December 31, 2020 | 0.181M |
September 30, 2020 | -0.481M |
June 30, 2020 | -0.439M |
March 31, 2020 | -1.081M |
December 31, 2019 | -1.581M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.581M
Minimum
Dec 2019
0.181M
Maximum
Dec 2020
-0.3424M
Average
-0.0155M
Median
Cash from Investing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |
Oragenics Inc | -0.9363M |